Two Risk Factors for Hypozincemia in Diabetic β-thalassemia Patients: Hepatitis C and Deferasirox

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2024 Jan 12

PMID 38215162

Authors

Hadi Darvishi-Khezri

Hossein Karami

Mohammad Naderisorki

Mobin Ghazaiean

Mehrnoush Kosaryan

Amir Mosanejad-Galchali

Aily Aliasgharian

Hasan Karami

Affiliations

Soon will be listed here.

Abstract

Background And Aim: Hypozincemia is a prevalent adverse consequence in diabetes mellitus (DM) and β-Thalassemia patients. We aimed to evaluate the level of serum zinc in β-thalassemia patients with DM and a risk assessment for hypozincemia.

Methods: The study population included transfusion-dependent thalassemia (TDT) and non-transfusion-dependent thalassemia (NTDT) with overt DM (fasting plasma glucose (FPG) ≥126 mg/dL, and/or 2-h plasma glucose≥200 mg/dL). Serum zinc concentration was measured by the colorimetric method, and the values below 70 μg/dL were defined as hypozincemia. Myocardial and liver T2*-weighted magnetic resonance imaging (MRI T2*, millisecond [ms]) were valued by a free contrast MRI. The demographic, clinical, paraclinical, and laboratory data were also recorded. The data belonged to the period from December 2018 until December 2020.

Results: Of 64 diabetic β-thalassemia patients, 41 cases had zinc data in their medical files (aged 38 ± 9 years, 48.8% female). 78.05% of patients (n = 32) were TDT, and 21.95% were NTDT (n = 9). The mean ± standard deviation of zinc level was 110.2 ± 127.6 μg/dL. The prevalence of hypozincemia was 9.76%, 95% confidence interval [CI] 0.27 to 19.24 (four cases). After controlling age, the odds of hypozincemia for using deferasirox (DFX) was 8.77, 95% CI 0.60 to 127.1. In β-thalassemia patients, the age-adjusted risk of hypozincemia was calculated at 15.85, 95% CI 0.47 to 529.3 for hepatitis C. The adjusted risk of hypozincemia based on age for antacid use was 6.34, 95% CI 0.39 to 102.7.

Conclusion: In light of this study, as well as hepatitis C, using DFX and antacids is associated with a high risk of hypozincemia amid diabetic β-thalassemia cases. However, upward bias should be taken into consideration.

References

Broeren M, Geerdink E, Vader H, van den Wall Bake A . Hypomagnesemia induced by several proton-pump inhibitors. Ann Intern Med. 2009; 151(10):755-6. DOI: 10.7326/0003-4819-151-10-200911170-00016. View

Wang X, Wu W, Zheng W, Fang X, Chen L, Rink L . Zinc supplementation improves glycemic control for diabetes prevention and management: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr. 2019; 110(1):76-90. DOI: 10.1093/ajcn/nqz041. View

Ozcelik D, Ozaras R, Gurel Z, Uzun H, Aydin S . Copper-mediated oxidative stress in rat liver. Biol Trace Elem Res. 2004; 96(1-3):209-15. DOI: 10.1385/BTER:96:1-3:209. View

Genc G, Ozturk Z, Gumuslu S, Kupesiz A . Mineral Levels in Thalassaemia Major Patients Using Different Iron Chelators. Biol Trace Elem Res. 2015; 170(1):9-16. DOI: 10.1007/s12011-015-0441-1. View

Tang X, Shay N . Zinc has an insulin-like effect on glucose transport mediated by phosphoinositol-3-kinase and Akt in 3T3-L1 fibroblasts and adipocytes. J Nutr. 2001; 131(5):1414-20. DOI: 10.1093/jn/131.5.1414. View

Alaarg A, Schiffelers R, van Solinge W, van Wijk R . Red blood cell vesiculation in hereditary hemolytic anemia. Front Physiol. 2014; 4:365. PMC: 3862113. DOI: 10.3389/fphys.2013.00365. View

Fung E, Gildengorin G, Talwar S, Hagar L, Lal A . Zinc status affects glucose homeostasis and insulin secretion in patients with thalassemia. Nutrients. 2015; 7(6):4296-307. PMC: 4488784. DOI: 10.3390/nu7064296. View

Muanprasat C, Wongborisuth C, Pathomthongtaweechai N, Satitsri S, Hongeng S . Protection against oxidative stress in beta thalassemia/hemoglobin E erythrocytes by inhibitors of glutathione efflux transporters. PLoS One. 2013; 8(1):e55685. PMC: 3561311. DOI: 10.1371/journal.pone.0055685. View

Rubin R . New Gene Therapy for β-Thalassemia. JAMA. 2022; 328(11):1030. DOI: 10.1001/jama.2022.14709. View

10.

Di Maggio R, Maggio A . The new era of chelation treatments: effectiveness and safety of 10 different regimens for controlling iron overloading in thalassaemia major. Br J Haematol. 2017; 178(5):676-688. DOI: 10.1111/bjh.14712. View

11.

Fung E, Ahmad T, Killilea D, Hussain R, Lal A . Zinc supplementation improves markers of glucose homeostasis in thalassaemia. Br J Haematol. 2020; 190(3):e162-e166. DOI: 10.1111/bjh.16771. View

12.

Farrell C, Morgan M, Rudolph D, Hwang A, Albert N, Valenzano M . Proton Pump Inhibitors Interfere With Zinc Absorption and Zinc Body Stores. Gastroenterology Res. 2016; 4(6):243-251. PMC: 5139861. DOI: 10.4021/gr379w. View

13.

Nimkarn N, Songdej D, Dumrongwongsiri O, Sirachainan N, Chuansumrit A . Age as a major factor associated with zinc and copper deficiencies in pediatric thalassemia. J Trace Elem Med Biol. 2021; 68:126817. DOI: 10.1016/j.jtemb.2021.126817. View

14.

Karunaratna A, Ranasingha J, Mudiyanse R . Zinc Status in Beta Thalassemia Major Patients. Biol Trace Elem Res. 2017; 184(1):1-6. DOI: 10.1007/s12011-017-1158-0. View

15.

Lin C, Huang J, Tsai L, Huang Y . Selenium, iron, copper, and zinc levels and copper-to-zinc ratios in serum of patients at different stages of viral hepatic diseases. Biol Trace Elem Res. 2006; 109(1):15-24. DOI: 10.1385/BTER:109:1:015. View

16.

Erdogan E, Canatan D, Ormeci A, Vural H, Aylak F . The effects of chelators on zinc levels in patients with thalassemia major. J Trace Elem Med Biol. 2012; 27(2):109-11. DOI: 10.1016/j.jtemb.2012.10.002. View

17.

Matter R, Elbarbary N, Rahman Ismail E, Darwish Y, Nada A, Banoub V . Zinc supplementation improves glucose homeostasis in patients with β-thalassemia major complicated with diabetes mellitus: A randomized controlled trial. Nutrition. 2020; 73:110702. DOI: 10.1016/j.nut.2019.110702. View

18.

Smith Jr J, Butrimovitz G, Purdy W . Direct measurement of zinc in plasma by atomic absorption spectroscopy. Clin Chem. 1979; 25(8):1487-91. View

19.

Ennes Dourado Ferro F, de Sousa Lima V, Mello Soares N, Franciscato Cozzolino S, do Nascimento Marreiro D . Biomarkers of metabolic syndrome and its relationship with the zinc nutritional status in obese women. Nutr Hosp. 2011; 26(3):650-4. DOI: 10.1590/S0212-16112011000300032. View

20.

Soliman A, DeSanctis V, Yassin M, Elalaily R, Eldarsy N . Continuous glucose monitoring system and new era of early diagnosis of diabetes in high risk groups. Indian J Endocrinol Metab. 2014; 18(3):274-82. PMC: 4056122. DOI: 10.4103/2230-8210.131130. View